Claret Capital Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.
BiotechHealthtechMedical DevicesKirkland, US
Frederick A. Stewart(Executive Officer, Director)Rick Wypych(Executive Officer)in
BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)Gerry Brunk(Director)
Co-investorsAPERTURE Venture PartnersLumira VenturesRedbus VenturesAlly Bridge GroupM.H. Carnegie & Co.
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsAct Venture CapitalACT Venture CapitalMolten VenturesSeroba Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.